头颈癌临床分期与病理分期不一致的模式
该回顾性队列纳入单中心10年间580例新诊断并手术的头颈鳞状细胞癌患者,比较临床与病理T、N分期。33%病例存在分期不一致,总体Cohen kappa为0.55(中度一致)。部分部位分期高度不一致,T2-4口腔癌常被高估,超过三分之一T3喉癌被低估。
要点
- 33%的头颈鳞癌患者临床与病理分期不一致,总体kappa为0.55(中度一致)。
- 高度不一致(kappa<0.45)包括T2口腔、T2口咽、T3喉和N1淋巴结。
- T2-4口腔癌常被高估,超过三分之一T3喉癌被低估。
核心结论
- 临床与病理分期之间存在可量化的、在某些部位具有临床意义的不一致模式。
- 肿瘤委员会多学科评估可突出这些差异并有助于限制对治疗决策的影响。
- 不一致的分期可影响预后判断、治疗应用和数据准确性。
- 需要进一步研究以提高高度不一致部位的临床分期准确性。
研究设计与样本
- 回顾性队列研究,纳入单中心10年间580例新诊断并手术的头颈鳞状细胞癌患者,比较临床与病理分期。
主要发现
- 33%的病例存在分期不一致。
- 总体Cohen kappa一致性为κ=0.55(中度一致)。
- 高度不一致(κ<0.45)的部位分期包括:T2口腔、T2口咽、T3喉和N1淋巴结。
- T2-4口腔癌常被高估,超过三分之一的T3喉癌被低估。
- 高度一致(κ>0.65)的部位分期包括:T1喉、T4口咽、N0淋巴结和N3淋巴结。
关键数值与推荐
- 总体一致性κ=0.55(中度一致)。
- 高度不一致定义为κ<0.45,包括T2口腔、T2口咽、T3喉和N1淋巴结。
- 高度一致定义为κ>0.65,包括T1喉、T4口咽、N0淋巴结和N3淋巴结。
临床怎么用
- 肿瘤委员会多学科评估可突出临床与病理分期差异并有助于限制对治疗决策的影响。
- 不一致的分期可影响预后判断、治疗应用和数据准确性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To enhance understanding in patterns of discordance between clinical and pathological T and N staging in multiple sites of head and neck squamous cell cancer. METHODS: A retrospective cohort of 580 newly diagnosed and surgically treated head and neck squamous cell carcinoma patients from a single institution over a 10-year period are presented. Clinical and pathologic staging are compared. RESULTS: Notably, 33% of cases had staging discordance. Overall Cohen's kappa agreement was κ = 0.55 (moderate agreement). Highly discordant site stages with κ < 0.45 included: T2 oral cavity, T2 oropharynx, T3 larynx, and N1 lymph node. T2-4 oral cavity cancers were often overstaged, and more than one-third of T3 larynx cancers were understaged. Highly concordant site stages with κ>0.65 included: T1 larynx, T4 oropharynx, N0 lymph node, and N3 lymph node. CONCLUSION: There exists a quantifiable and, in certain sites, clinically relevant pattern of discordance between clinical and pathologic staging. Tumor board multidisciplinary evaluation can highlight these discrepancies and aide in limiting effects on treatment decisions. However, discordant staging can affect the interpretation and application of prognostication, treatment, and data accuracy. Further investigation is warranted to improve clinical staging accuracy in areas of highest discordance. LEVEL OF EVIDENCE: 3 Laryngoscope, 134:4284-4291, 2024.
引用
- Hondorp B, Punjabi N, Macias D, et al. Patterns of Discordance Between Clinical and Pathologic Stage in Head and Neck Cancer. Laryngoscope. 2024. PMID: 38656702. doi:10.1002/lary.31465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。